|
Accueil > Actualité
Bayer: progress report in menopause treatment
(CercleFinance.com) - Bayer announces that it will present additional research results from two Phase III studies of elinzanetant for the treatment of menopausal symptoms at the European Society of Gynecology (ESG) Congress, on 19-22 March in Riga, Latvia.
The results will focus on the impact of sleep disorders on women's health and quality of life, and the effect of elinzanetant on the treatment of vasomotor symptoms associated with menopause. They will also be analyzed by pooling data from several sub-group analyses from two Phase III studies of elinzanetant. Copyright (c) 2025 CercleFinance.com. All rights reserved. |
18/03/2025 13:18
Idsudrelèvement du prix de l'OPAS 18/03/2025 13:01 Goldman Sachsl'UE approuve l'opération sur OMH HealthEdge 18/03/2025 12:49 AtosEviden choisi par la CANUT pour un accord-cadre AMOE 18/03/2025 12:31 Deutsche Bankcoopération 'stratégique' avec l'allemand DWS 18/03/2025 12:19 Holciml'UE autorise la coacquisition de BGC Cementitious 18/03/2025 11:45 SpiePeugeot Invest cède la moitié de sa participation Tous les articles sociétés |
